2024
The Use and Impact of Cilostazol on Patients Undergoing Endovascular Peripheral Interventions
Alameddine D, Damara F, Pinto Rodriguez P, Huttler J, Slade M, Arhuidese I, Aboian E, Ochoa Chaar C. The Use and Impact of Cilostazol on Patients Undergoing Endovascular Peripheral Interventions. Annals Of Vascular Surgery 2024, 103: 47-57. PMID: 38387798, DOI: 10.1016/j.avsg.2023.12.071.Peer-Reviewed Original ResearchImpact of cilostazolPeripheral vascular interventionsPeripheral arterial diseaseTreatment of intermittent claudicationRates of long-term mortalityPeripheral vascular interventional proceduresKaplan-Meier methodCongestive heart failureLong-term mortalityLong-term outcomesEndovascular peripheral interventionsRenal complicationsPatient demographicsBaseline characteristicsHeart failureDiabetes mellitusArtery diseaseIntermittent claudicationCilostazolPatientsVascular interventionsPeripheral interventionsClaudicationOutcomesIntervention
2022
Association of Renin-Angiotensin-Aldosterone System Inhibitor Usage Patterns with Midterm Amputation-Free Survival after Lower Extremity Bypass for Peripheral Arterial Disease
Naazie I, Arhuidese I, Abdelgawwad M, Unkart J, Conte M, Malas M. Association of Renin-Angiotensin-Aldosterone System Inhibitor Usage Patterns with Midterm Amputation-Free Survival after Lower Extremity Bypass for Peripheral Arterial Disease. Annals Of Vascular Surgery 2022, 88: 79-89. PMID: 36028182, DOI: 10.1016/j.avsg.2022.07.022.Peer-Reviewed Original ResearchConceptsRenin-angiotensin-aldosterone system inhibitor useRenin-angiotensin-aldosterone system inhibitorsLower extremity bypassAmputation-free survivalPeripheral arterial diseaseArtery diseaseAssociated with improved 30-day mortalityAssociated with improved survivalAssociated with 2.8-foldPeripheral arterial disease patientsLEB outcomesArtery disease patientsLower-extremity bypassSurvival benefitSystem inhibitorsPostoperative periodRAAS inhibitionStudy cohortCox regressionPrimary outcomePotential confoundersIncreased oddsDisease patientsPatientsMortality
2021
Association of Angiotensin Converting Enzyme Inhibitor Usage Patterns with Mortality after Lower Extremity Bypass for Peripheral Arterial Disease
Naazie I, Unkart J, Arhuidese I, Malas M. Association of Angiotensin Converting Enzyme Inhibitor Usage Patterns with Mortality after Lower Extremity Bypass for Peripheral Arterial Disease. Journal Of The American College Of Surgeons 2021, 233: s317-s318. DOI: 10.1016/j.jamcollsurg.2021.07.658.Peer-Reviewed Original ResearchContinuous ACE Inhibitor Use Is Associated With Improved Perioperative and Long-term Mortality Benefit in Patients Undergoing Lower Extremity Bypass for Peripheral Arterial Disease
Naazie I, Unkart J, Arhuidese I, Siracuse J, Malas M. Continuous ACE Inhibitor Use Is Associated With Improved Perioperative and Long-term Mortality Benefit in Patients Undergoing Lower Extremity Bypass for Peripheral Arterial Disease. Journal Of Vascular Surgery 2021, 74: e254-e255. DOI: 10.1016/j.jvs.2021.06.376.Peer-Reviewed Original Research
2020
Safety of carotid artery revascularization procedures in patients with atrial fibrillation
Nejim B, Mathlouthi A, Weaver L, Faateh M, Arhuidese I, Malas M. Safety of carotid artery revascularization procedures in patients with atrial fibrillation. Journal Of Vascular Surgery 2020, 72: 2069-2078.e4. PMID: 32471737, DOI: 10.1016/j.jvs.2020.01.074.Peer-Reviewed Original ResearchMeSH KeywordsAgedAged, 80 and overAtrial FibrillationCarotid Artery DiseasesCerebral HemorrhageCross-Sectional StudiesDatabases, FactualEndarterectomy, CarotidEndovascular ProceduresFemaleHospital MortalityHumansMaleMiddle AgedRetrospective StudiesRisk AssessmentRisk FactorsStentsStrokeTime FactorsTreatment OutcomeUnited StatesConceptsCarotid artery stentingInternational Classification of DiseasesClinical Modification codesClassification of DiseasesOdds of intracerebral hemorrhagePredictors of ischemic strokeIntracerebral hemorrhageMultivariate logistic modelIn-hospital strokeCarotid artery diseaseCarotid endarterectomyHospital sizeAFib patientsInternational ClassificationModification codesHealthcare databasesMedication useStatistically significant predictorsAdjusted analysesAtrial fibrillationRandomized clinical trialsArtery diseasePremier Healthcare DatabaseAssociated with worse postoperative outcomesCarotid artery revascularization procedures
2017
Racial disparities after infrainguinal bypass surgery in hemodialysis patients
Arhuidese I, Wang S, Locham S, Faateh M, Nejim B, Malas M. Racial disparities after infrainguinal bypass surgery in hemodialysis patients. Journal Of Vascular Surgery 2017, 66: 1163-1174. PMID: 28647200, DOI: 10.1016/j.jvs.2017.04.044.Peer-Reviewed Original ResearchMeSH KeywordsAgedAmputation, SurgicalBlack or African AmericanBlood Vessel Prosthesis ImplantationChi-Square DistributionDatabases, FactualFemaleHealthcare DisparitiesHispanic or LatinoHumansKaplan-Meier EstimateKidney DiseasesLimb SalvageLogistic ModelsMaleMedicareMiddle AgedMultivariate AnalysisOdds RatioPeripheral Arterial DiseasePostoperative ComplicationsProcess Assessment, Health CarePropensity ScoreProportional Hazards ModelsRenal DialysisRetrospective StudiesRisk FactorsTime FactorsTreatment OutcomeUnited StatesVascular PatencyWhite PeopleConceptsInfrainguinal bypass surgeryGraft failureHD patientsPeripheral arterial diseaseLimb salvageBypass surgeryEvaluate long-term graft patencyArtery diseaseWhite patientsGraft patencyBlack patientsSurgical treatment of peripheral arterial diseaseLong-term graft failurePrimary assisted patencyAcute graft failureCox regression analysisLong-term mortalityLong-term graft patencyAll-cause mortalityLimb lossTreatment of peripheral arterial diseasePopliteal-tibial bypassAssisted patencyPrimary patencySecondary patency
2016
Outcomes after open infrainguinal bypass in patients with scleroderma
Arhuidese I, Malas M, Obeid T, Massada K, Khaled A, Alzahrani A, Samaha G, Reifsnyder T. Outcomes after open infrainguinal bypass in patients with scleroderma. Journal Of Vascular Surgery 2016, 64: 117-123. PMID: 27005756, DOI: 10.1016/j.jvs.2015.12.057.Peer-Reviewed Original ResearchMeSH KeywordsAgedAged, 80 and overAutograftsBaltimoreCritical IllnessFemaleGraft SurvivalHumansIschemiaKaplan-Meier EstimateLimb SalvageLower ExtremityMaleMiddle AgedMultivariate AnalysisPeripheral Arterial DiseaseProportional Hazards ModelsRetrospective StudiesRisk FactorsSaphenous VeinScleroderma, SystemicSeverity of Illness IndexTime FactorsTreatment OutcomeVascular GraftingVascular PatencyConceptsInfrainguinal bypass surgeryLong-term outcomesBypass surgerySystemic sclerosisGraft failureSociety for Vascular Surgery standardsScleroderma patientsArtery diseaseFollow-up durationStandard deviation ageCox regression analysisSevere peripheral arterial diseaseHistory of hypertensionLower extremity bypassCoronary artery diseaseLimb salvage rateCritical limb ischemiaPeripheral arterial diseaseDeviation ageReporting of outcomesKaplan-MeierPoor outcomeSalvage rateInfrainguinal bypassLimb ischemia